SCHEMBL6573307

SCHEMBL6573307

NCCNCCNCc1ccc(N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 2/20 0.50
MC5R P33032 2/20 0.50
CHRM2 P08172 5/20 0.47
TDP1 Q9NUW8 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
CA12 O43570 2/20 0.46
CA6 P23280 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
CA5B Q9Y2D0 2/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA3 P07451 1/20 0.46
ALOX15 P16050 1/20 0.46
CA4 P22748 1/20 0.46
CA5A P35218 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11049168 0.96 MC4R (0.53) MC4RMC5RCHRM2TDP1MEN1
Acetic Acid SCHEMBL10379151 0.88 ITGB1 (0.42) MC4RMC5RCHRM2TDP1MEN1
SCHEMBL10873668 0.88 MC4R (0.56) MC4RMC5RCHRM2MEN1KMT2A
SCHEMBL13521675 0.87 MC4R (0.61) MC4RMC5RCHRM2TDP1MEN1
SCHEMBL11120368 0.87 CA12 (0.61) TDP1MEN1KMT2ALMNACA12
Acetic Acid SCHEMBL10434078 0.83 ITGB1 (0.44) MC4RMC5RCHRM2MEN1KMT2A
SCHEMBL6575879 0.83 MC4R (0.53) MC4RMC5RCHRM2TDP1KMT2A
SCHEMBL13528546 0.82 MAOA (0.60) MC4RMC5RCHRM2TDP1MEN1
SCHEMBL4909529 0.82 CHRM2 (0.71) MC4RMC5RCHRM2TDP1MEN1
SCHEMBL6013974 0.82 CA1 (0.50) MC4RMC5RCHRM2TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0785928-B1 NOVEL N3 S2 CHELATING LIGANDS OPTIONALLY RADIOLABELLED WITH Tc OR Re, USEFUL FOR DIAGNOSTIC OR THERAPEUTIC APPLICATIONS MERCK FROSST CANADA INC (CA) 2004-04-28 EP disclosed
EP-0785951-B1 TC OR RE RADIOLABELLED SOMATOSTATIN ANALOGS MERCK FROSST CANADA INC (CA) 2002-04-24 EP disclosed
EP-0785928-A1 NOVEL N3 S2 CHELATING LIGANDS OPTIONALLY RADIOLABELLED WITH Tc OR Re, USEFUL FOR DIAGNOSTIC OR THERAPEUTIC APPLICATIONS MERCK FROSST CANADA INC. (CA) 1997-07-30 EP disclosed
EP-0785951-A1 TC OR RE RADIOLABELLED SOMATOSTATIN ANALOGS MERCK FROSST CANADA INC. (CA) 1997-07-30 EP disclosed
US-5632969-A N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications MERCK & CO., INC. (US) 1997-05-27 US disclosed
US-5556939-A TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications MERCK FROSST CANADA, INC. (CA) 1996-09-17 US disclosed
WO-1996011954-A1 TC OR RE RADIOLABELLED SOMATOSTATIN ANALOGS MERCK FROSST CANADA INC. (CA) 1996-04-25 WO disclosed
WO-1996011918-A1 NOVEL N3S2 CHELATING LIGANDS OPTIONALLY RADIOLABELLED WITH Tc OR Re, USEFUL FOR DIAGNOSTIC OR THERAPEUTIC APPLICATIONS MERCK FROSST CANADA INC. (CA) 1996-04-25 WO disclosed